Malaria, a parasitic infection caused by the genus Plasmodium, results to over 20 million reported cases annually worldwide. Most individuals exhibit various symptoms, and blood analysis plays a crucial role in determining the appropriate treatment approach. This study discusses various hematologic complications associated with different Plasmodium species. A review of scientific databases including PubMed, Science Direct, Web of Science, Scopus, EMBASE, Magiran, SID, IranMedex was conducted using standard keywords such as Plasmodium, malaria, anemia and blood disorders (hematologic disorder) between 2000 and 2024. The review focused on articles pertaining to clinical trials, prospective cohort, retrospective, cross-sectional and case-control studies. Articles evaluating the effects of malaria on blood cells and indices, with target groups including human and animals, were included. Articles not written in English or Farsi were excluded. Our review revealed that, apart from iron deficiency anemia and vascular dysfunction contributed in part by adhesion of infected RBC to endothelium, decreases in hematocrit and hemoglobin levels, as part of pancytopenia and thrombocytopenia, are characteristic of Plasmodium infection. Additionally, the occurrence of inflammation due to the release of inflammatory cytokines and complement activation can complicate the clinical features of malaria in individuals with hematologic conditions.
Keyphrases
- plasmodium falciparum
- iron deficiency
- case control
- cross sectional
- clinical trial
- public health
- oxidative stress
- chronic kidney disease
- induced apoptosis
- nitric oxide
- risk factors
- signaling pathway
- cell cycle arrest
- randomized controlled trial
- cell death
- artificial intelligence
- cell proliferation
- staphylococcus aureus
- single cell
- escherichia coli
- physical activity
- open label
- data analysis
- induced pluripotent stem cells
- endoplasmic reticulum stress
- phase iii
- phase ii